Source comparison
Comparison: Air Bubble Risk Across Injection Routes
Subcutaneous (peptides) 29–31G, 4–6mm depth >5mL (no documented events below this) 0.3–1.0mL total capacity Negligible. Air dissipates in tissue Intramuscular (vaccines) 22–25G, 25–38mm depth >20mL (theoretical; no case reports) 1.0–3.0mL typical dose Negligib
This comparison does not assign a generated winner or score.
- Subcutaneous (peptides)
- 29–31G, 4–6mm depth
- >5mL (no documented events below this)
- 0.3–1.0mL total capacity
- Negligible. Air dissipates in tissue
- Intramuscular (vaccines)
- 22–25G, 25–38mm depth
- >20mL (theoretical; no case reports)
- 1.0–3.0mL typical dose
- Negligible. Tissue absorption
- Intravenous (hospital IV)
- 18–22G, direct vein access
- 100–300mL (clinical threshold for embolism)
- N/A
- Moderate to high if threshold reached
- Intra-articular (joint)
- 20–22G, into joint space
- <1mL causes discomfort, not danger
- 1.0–5.0mL typical volume
- Low. Air absorbed or expelled